← Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
📢 Press Releases
Date | Press release |
---|---|
2025-04-25 06:55:00 | Sensient Technologies Corporation Reports Results For The Quarter Ended March 31, 2025 Milwaukee--(business wire)--sensient technologies corporation (nyse: sxt), a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, today reported financial results for the first quarter ended march 31, 2025. first quarter consolidated results reported revenue increased 2.0% to $392.3 million in the first quarter of 2025 versus last year’s first quarter results of $384.7 million. on a local currency basis(1), revenue increased 4.1%. reported operating in. |
2025-04-24 18:37:00 | Sensient Declares Dividend Milwaukee--(business wire)--the board of directors of sensient technologies corporation (nyse: sxt) has declared a regular quarterly cash dividend on its common stock of $0.41 per share. the cash dividend will be paid on june 2, 2025, to shareholders of record on may 12, 2025. about sensient technologies sensient technologies corporation is a leading global manufacturer and marketer of colors, flavors, and other specialty ingredients. sensient uses advanced technologies and robust global supply. |
2025-04-11 17:30:00 | Sensient Announces Conference Call Milwaukee--(business wire)--sensient technologies corporation (nyse: sxt) will hold its earnings call and webcast to discuss 2025 first quarter results at 8:30 a.m. cdt on friday, april 25, 2025. investors may access the live webcast on the company’s web site at investor.sensient.com. alternatively, investors may join the conference call by contacting chorus call inc. at (844) 492-3726 or (412) 317-1078. a webcast replay will be available on the company’s web site following the call. the call t. |
2025-03-17 08:30:00 | China Sxt Pharmaceuticals Has Regained Compliance With Nasdaq’s Minimum Bid Price Deficiency Taizhou, china, march 17, 2025 (globe newswire) -- china sxt pharmaceuticals, inc. (nasdaq: sxtc) (the “company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of traditional chinese medicine pieces (“tcmps”), including advanced tcmps (directly-oral tcmp and after-soaking-oral tcmp), fine tcmps, regular tcmps, and tcm homologous supplements (“tcmhs”), today announced that the company received a written notification (the “compliance notice”) from the listing qualifications department of the nasdaq stock market llc (“nasdaq”) dated march 13, 2025, informing the company that it has regained compliance with the nasdaq listing rule 5550(a)(2) (“minimum bid price requirement”) and the matter is closed. |
2025-02-21 12:35:00 | China Sxt Pharmaceuticals, Inc. Announces Share Consolidation Taizhou, china, feb. 21, 2025 (globe newswire) -- china sxt pharmaceutics, inc. (nasdaq: sxtc) (the “company” or “sxtc”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of traditional chinese medicine pieces (“tcmps”), including advanced tcmps (directly-oral tcmp and after-soaking-oral tcmp), fine tcmps, regular tcmps, and tcm homologous supplements (“tcmhs”), today announced that it will effect a share consolidation of its ordinary shares at a ratio of 1-for-8, effective on february 25, 2025 (the “share consolidation”). the company’s ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on february 25, 2025. upon the market opening on february 25, 2025, the company’s ordinary shares will continue to be traded on the nasdaq stock market under the symbol “sxtc” with the new cusip number g2161p157. |
2025-02-14 06:55:00 |
|
2025-01-31 18:49:00 |
|
2025-01-17 17:41:00 |
|
2024-10-25 06:50:00 |
|
2024-10-24 18:37:00 |
|
2024-10-11 17:00:00 |
|
2024-10-07 16:15:00 |
|
2024-07-25 17:00:00 |
|
2024-07-12 17:17:00 |
|
2024-04-26 06:55:00 |
|

📰 Browse additional press releases for Sensient Technologies!
Sign up for free or log in📥 Get our free eBook now: "The Checklist Value Investor — A Smarter Way to Pick Stocks"